iproniazid has been researched along with Anxiety Disorders in 3 studies
Anxiety Disorders: Persistent and disabling ANXIETY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| ARNOT, R | 1 |
| Aimard, G | 1 |
| Garde, A | 1 |
| Henry, E | 1 |
| Sevez, JF | 1 |
| Sheehan, DV | 1 |
1 review available for iproniazid and Anxiety Disorders
| Article | Year |
|---|---|
Monoamine oxidase inhibitors and alprazolam in the treatment of panic disorder and agoraphobia.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Cheese; Diet; Drug-Related Side | 1985 |
2 other studies available for iproniazid and Anxiety Disorders
| Article | Year |
|---|---|
Calming effect of the monoamine oxidase inhibitors.
Topics: Anxiety; Anxiety Disorders; Hydroxyzine; Iproniazid; Monoamine Oxidase Inhibitors; Oxidoreductases | 1960 |
[Plea for monoamine oxidase inhibitors. Retrospective study of 350 cases].
Topics: Adult; Aged; Anesthesia, General; Anxiety Disorders; Depressive Disorder; Female; Headache; Humans; | 1984 |